Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
about
Interleukin-32 promotes osteoclast differentiation but not osteoclast activationEmerging Functions of RANKL in Lymphoid TissuesTumor metastasis to boneBiology of RANK, RANKL, and osteoprotegerinLIGHT, a member of the tumor necrosis factor ligand superfamily, prevents tumor necrosis factor-alpha-mediated human primary hepatocyte apoptosis, but not Fas-mediated apoptosisFLRG, a new ADAM12-associated protein, modulates osteoclast differentiationReceptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6The gene for cherubism maps to chromosome 4p16.IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisGiant cell tumour of bone: morphological, biological and histogenetical aspectsRANK is essential for osteoclast and lymph node developmentA comprehensive manually curated reaction map of RANKL/RANK-signaling pathwayControl of RANKL gene expressionActivated human T cells express alternative mRNA transcripts encoding a secreted form of RANKLRole of NADPH oxidase in formation and function of multinucleated giant cellsDenosumabTumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligandOsteoimmunology: interactions of the bone and immune systemIdentification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiationEffect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexateJun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKLA novel member of the leukocyte receptor complex regulates osteoclast differentiationGene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formationOsteoclasts: what do they do and how do they do it?Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone lossExposure to receptor-activator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiationThe role of osteoprotegerin in arthritisDifferentiation of monocytes into multinucleated giant bone-resorbing cells: two-step differentiation induced by nurse-like cells and cytokinesEnhanced osteoclast development in collagen-induced arthritis in interferon-gamma receptor knock-out mice as related to increased splenic CD11b+ myelopoiesisBone loss. Factors that regulate osteoclast differentiation: an update.The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption.The molecular mechanism of osteoclastogenesis in rheumatoid arthritisThe osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitroIn Vitro Co-Culture Models of Breast Cancer Metastatic Progression towards BoneRANK-RANKL signalling in cancerRole of EMT in Metastasis and Therapy ResistanceThe Modulatory Effects of Mesenchymal Stem Cells on OsteoclastogenesisAnimal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive ReviewCaldecrin: A pancreas-derived hypocalcemic factor, regulates osteoclast formation and functionHost response mechanisms in periodontal diseases
P2860
Q21092154-1D8A5BB8-D329-477E-9B8B-CAC9A0CD8535Q21131222-A5794F76-4A6F-4A32-924D-68102A31C5D0Q21195416-9D079B93-6673-4AF3-9816-D4A343163128Q21195419-40195906-9237-40D7-A1BC-4567A2BB864EQ24312907-7D4DBCB3-AE7A-4124-8629-774D38B5A515Q24318438-B4F21269-A989-4516-B99F-09A4C7C5BC79Q24537518-CEECAFE9-A43D-495E-B10D-D51787AC7035Q24540306-86F68B14-A0BD-4A89-BF33-B5F5754B3E4FQ24563235-3205F067-444B-4CDA-B8C4-412DF8629F84Q24595415-6C48B6C7-2139-4128-81C4-13E5A03335E2Q24598872-ED5C32B0-AE6B-4E87-9F91-4EF6E1C44BE5Q24599024-8E923773-01C7-41CA-9244-AD77897ED8D4Q24619669-55E724EB-AD93-4468-BC29-9060DDFE3E0BQ24632345-81A57123-160B-49E5-87CE-CBCBE7D5E9FCQ24633426-3B68D3E4-95BC-474D-9C0F-A308F2B987BFQ24651938-1D9660DC-502B-4A66-AEB3-F2F9F125F56BQ24653311-0831B116-BA6F-49EA-9F18-88D0D0B19E21Q24655113-76F5A9BD-97C9-44DB-8BF3-341A4D270096Q24657159-0617B1F1-4F71-4966-BCF2-D75452E86C02Q24658507-039DDC7E-B4FD-4878-9338-CBB3203A3BB2Q24673624-E8E0AC70-5DBB-470F-9EEE-A71661213F99Q24675157-3A3229D5-33FE-46C9-9BFD-ECBA28B38A9CQ24681552-811E4376-A68C-4044-B1DD-D60E7AD075E1Q24683898-3D6FC38C-4B8E-45CB-A493-246C1C17742BQ24701798-8ED473F5-F7E0-4D05-ABDA-E4C4460AB007Q24796088-45E6641C-7824-440F-8442-3FE4EC2C072BQ24797889-6EEE7843-B62C-4198-8A20-86E330B64644Q24799753-B8FF7C88-725E-423C-BDA5-B30F4AA3BB7AQ24800726-FF82F108-0339-4964-A2BB-9C0D416BEBA1Q24805142-3BC35328-F6B6-4DDA-84B1-D4A24358A282Q24805207-DC08A95F-07F5-4424-AD55-8AA90A4A72E1Q24806322-1FE01211-225B-412B-8E61-93F65641BD28Q24816632-3BED801F-17B6-43A3-AEB6-96E232663651Q26738435-C2BBA8BD-8A97-4C75-A05F-E408980A17B7Q26747442-C76D8F60-D01C-413C-8959-11953D8982EBQ26772923-6323D84D-FAB7-4AD4-9FD4-589771931361Q26773017-191CE7C9-F434-4537-8646-0011A5BF29AAQ26774874-36C575F2-F08D-4CE4-81CF-41A02AD24ABCQ26775406-0FC7D8AE-4D3C-4EFB-98CC-5817D3D7F23FQ26801846-3E01325F-AB84-4766-ACCA-B81F36FA98ED
P2860
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL
@ast
Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL
@en
Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL
@nl
type
label
Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL
@ast
Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL
@en
Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL
@nl
prefLabel
Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL
@ast
Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL
@en
Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL
@nl
P2093
P2860
P3181
P356
P1476
Osteoclast differentiation fac ...... d is identical to TRANCE/RANKL
@en
P2093
A Murakami
A Tomoyasu
K Higashio
K Yamaguchi
M Kinosaki
N Nakagawa
P2860
P304
P3181
P356
10.1073/PNAS.95.7.3597
P407
P577
1998-03-31T00:00:00Z